ニュース

The National Institute for Health and Care Excellence1 時間
Thousands could benefit from first immunotherapy for severe birch tree pollen allergy
The recommendation of betula verrucosa is the first NICE approval for an under-the-tongue immunotherapy for these conditions. Unlike conventional treatments that merely mask symptoms, this ...
The National Institute for Health and Care Excellence4 日
Thousands more breast cancer patients to benefit from new NHS treatment
Around 5,700 people with early breast cancer are set to benefit from expanded access to a treatment combination designed to help prevent their cancer from returning, following our recommendation, ...
The National Institute for Health and Care Excellence5 日
NICE responds to publication of the government’s Life Sciences Sector Plan
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing ...
The National Institute for Health and Care Excellence6 日
New cystic fibrosis drug fast-tracked for NHS use
Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...
The National Institute for Health and Care Excellence5 日
Four AI technologies conditionally recommended that could help spot hidden spinal fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans have been conditionally recommended in draft guidance.